17-30329452-A-G
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_206832.3(TMIGD1):āc.160T>Cā(p.Cys54Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000935 in 1,614,216 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000072 ( 0 hom., cov: 31)
Exomes š: 0.000096 ( 0 hom. )
Consequence
TMIGD1
NM_206832.3 missense
NM_206832.3 missense
Scores
10
6
3
Clinical Significance
Conservation
PhyloP100: 6.06
Genes affected
TMIGD1 (HGNC:32431): (transmembrane and immunoglobulin domain containing 1) Involved in several processes, including negative regulation of apoptotic process; regulation of cell migration; and regulation of membrane permeability. Located in cytoplasm and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.987
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMIGD1 | NM_206832.3 | c.160T>C | p.Cys54Arg | missense_variant | 3/7 | ENST00000328886.5 | NP_996663.1 | |
TMIGD1 | NM_001319942.2 | c.160T>C | p.Cys54Arg | missense_variant | 3/6 | NP_001306871.1 | ||
TMIGD1 | XM_011524787.2 | c.160T>C | p.Cys54Arg | missense_variant | 3/7 | XP_011523089.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMIGD1 | ENST00000328886.5 | c.160T>C | p.Cys54Arg | missense_variant | 3/7 | 1 | NM_206832.3 | ENSP00000332404 | P1 | |
TMIGD1 | ENST00000538566.6 | c.160T>C | p.Cys54Arg | missense_variant | 3/6 | 2 | ENSP00000446118 |
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152236Hom.: 0 Cov.: 31
GnomAD3 genomes
AF:
AC:
11
AN:
152236
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000115 AC: 29AN: 251306Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135798
GnomAD3 exomes
AF:
AC:
29
AN:
251306
Hom.:
AF XY:
AC XY:
16
AN XY:
135798
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000958 AC: 140AN: 1461862Hom.: 0 Cov.: 31 AF XY: 0.0000894 AC XY: 65AN XY: 727238
GnomAD4 exome
AF:
AC:
140
AN:
1461862
Hom.:
Cov.:
31
AF XY:
AC XY:
65
AN XY:
727238
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152354Hom.: 0 Cov.: 31 AF XY: 0.0000940 AC XY: 7AN XY: 74502
GnomAD4 genome
AF:
AC:
11
AN:
152354
Hom.:
Cov.:
31
AF XY:
AC XY:
7
AN XY:
74502
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
1
ExAC
AF:
AC:
9
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 09, 2024 | The c.160T>C (p.C54R) alteration is located in exon 3 (coding exon 2) of the TMIGD1 gene. This alteration results from a T to C substitution at nucleotide position 160, causing the cysteine (C) at amino acid position 54 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D
MetaSVM
Pathogenic
D
MutationAssessor
Uncertain
M;M
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D
REVEL
Pathogenic
Sift
Pathogenic
D;D
Sift4G
Pathogenic
D;D
Polyphen
D;D
Vest4
MutPred
Gain of disorder (P = 0.0403);Gain of disorder (P = 0.0403);
MVP
MPC
0.26
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at